By Carlos N Velez2025-03-13T09:48:49
AI-driven drug development, powered by advanced models and expanding data access, is becoming a reality. Learn why navigating regulatory hurdles and mastering biology’s inherent complexities are crucial to fully unlocking its potential.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2025-09-18T12:00:00
Sponsored by Benchling
2023-04-12T15:28:08
Sponsored by nanoComposix
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
Site powered by Webvision Cloud